Dermapharm Holding SE buy PapaSmurf
Start price
16.10.22
/
50%
€41.22
Target price
16.10.23
-
Performance (%)
-4.17%
End price
06.03.23
€39.50
Summary
This prediction ended on 06.03.23 with a price of €39.50. With a performance of -4.17%, the BUY prediction by PapaSmurf finished with a loss. PapaSmurf has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 0.871% | 0.871% | 19.970% | -13.169% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% | 64.713% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% | 88.244% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% | 79.311% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% | 69.603% |